Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH
Authors
Keywords
Gene expression, Inflammation, Fatty liver, Steatosis, Fibrosis, Liver fibrosis, Mouse models, Lipids
Journal
PLoS One
Volume 13, Issue 5, Pages e0194568
Publisher
Public Library of Science (PLoS)
Online
2018-05-31
DOI
10.1371/journal.pone.0194568
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design
- (2016) Zheng-Jie Xu et al. ADVANCES IN THERAPY
- Treatment of Non-Alcoholic Fatty Liver Disease
- (2016) Antonia Scherer et al. DIGESTIVE DISEASES
- Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients
- (2016) Evan Stein et al. Journal of Clinical Lipidology
- NAFLD and diabetes mellitus
- (2016) Herbert Tilg et al. Nature Reviews Gastroenterology & Hepatology
- Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
- (2016) Eric Lefebvre et al. PLoS One
- Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
- (2015) Samar H. Ibrahim et al. DIGESTIVE DISEASES AND SCIENCES
- Hepatic inflammation and fibrosis: Functional links and key pathways
- (2015) Ekihiro Seki et al. HEPATOLOGY
- Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2015) Su Jong Yu et al. MEDICINE
- Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis
- (2015) Kosuke Saito et al. Scientific Reports
- Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease
- (2015) Mariana Verdelho Machado et al. PLoS One
- The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis
- (2015) Emma L. Anderson et al. PLoS One
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonalcoholic Fatty Liver Disease Is Associated with Aortic Valve Sclerosis in Patients with Type 2 Diabetes Mellitus
- (2014) Stefano Bonapace et al. PLoS One
- Apolipoprotein C3(-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population
- (2014) Min-Rui Li WORLD JOURNAL OF GASTROENTEROLOGY
- Hepatic inflammation and progressive liver fibrosis in chronic liver disease
- (2014) Albert J Czaja WORLD JOURNAL OF GASTROENTEROLOGY
- Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
- (2013) Yuki Kawano et al. JOURNAL OF GASTROENTEROLOGY
- A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma
- (2013) Masato Fujii et al. Medical Molecular Morphology
- Pharmacological agents for NASH
- (2013) Vlad Ratziu Nature Reviews Gastroenterology & Hepatology
- Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
- (2013) Takumi Hirata et al. International Journal of Endocrinology
- Inhibition of hepatic sulfatase-2 In Vivo: A novel strategy to correct diabetic dyslipidemia
- (2012) H. Carlijne Hassing et al. HEPATOLOGY
- Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance
- (2011) Hui-Young Lee et al. HEPATOLOGY
- Expression of Perilipin and Adipophilin in Nonalcoholic Fatty Liver Disease; Relevance to Oxidative Injury and Hepatocyte Ballooning
- (2011) Hideki Fujii et al. Journal of Atherosclerosis and Thrombosis
- NASH animal models: Are we there yet?
- (2011) Rohit Kohli et al. JOURNAL OF HEPATOLOGY
- Increased production of sonic hedgehog by ballooned hepatocytes
- (2011) Fatima Rangwala et al. JOURNAL OF PATHOLOGY
- Recent insights into factors affecting remnant lipoprotein uptake
- (2010) Kevin Jon Williams et al. CURRENT OPINION IN LIPIDOLOGY
- Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c
- (2010) P. Ferré et al. DIABETES OBESITY & METABOLISM
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
- (2010) Susan S. Baker et al. PLoS One
- Hepatic Expression Patterns of Inflammatory and Immune Response Genes Associated with Obesity and NASH in Morbidly Obese Patients
- (2010) Adeline Bertola et al. PLoS One
- Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status
- (2009) Lance L. Stein et al. ADVANCES IN THERAPY
- Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis
- (2009) Koji Fujita et al. HEPATOLOGY
- Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
- (2008) Esther M. M. Ooi et al. CLINICAL SCIENCE
- A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
- (2008) T. I. Pollin et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started